RIGL
Rigel Pharmaceuticals, Inc. 9/1/2025, 5:36:45 PM
NasdaqGS
USD
EQUITY
At Close
$38.85
+27.05 (+229.24%)
Volume
846,491
Market Cap
696.86M
NasdaqGS
Period
No AI Analysis Available
Generate a comprehensive AI analysis for RIGL to get insights on valuation, growth prospects, and investment recommendations.
Valuation
-
Profitability
376.1%
39.0%
61.3%
82.8%
39.0%
36.5%
Growth
105.6%
45.8%
-
-
-
Financial Health
Forward Looking
Buy
$38.20
$472.64
$-32.05
Small-Cap
Risk & Technical
1.21
$43.72 / $12.66
68.57
12.3%
Shareholder Returns
-
-
-
-3.0%
9.4%